HeartR™ PDA Occluder Post-Market Follow-Up Study

Abroad (travel likely)Recruiting

Conditions

Patent Ductus Arteriosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

RS Awal Bros, Pekanbaru, Riau, Indonesia
Contact: Study coordinator (Shirley Leonita Anggriawan, Dr. Sp.A (K) · mkt.pku@awalbros.com · 0761-47333
Contact: Principal Investigator (Shirley Leonita Anggriawan, Dr. Sp.A (K)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PDA for Kidneys Study

Patent Ductus Arteriosus · Congenital Heart Disease

Abroad (travel likely)Recruiting

Madison, United States

NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

Preterm · Patent Ductus Arteriosus · Sepsis

Abroad (travel likely)Recruiting

Trondheim, Norway

Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants

Patent Ductus Arteriosus After Premature Birth

Abroad (travel likely)RecruitingPHASE2

Newcastle, Australia · St Leonards, Australia

Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

Patent Ductus Arteriosus

Abroad (travel likely)Recruiting

Montreal, Canada · Lille, France